We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

87 hedge funds and large institutions have $884M invested in GW Pharmaceuticals Plc American Depositary Shares in 2014 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 11

125% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 16

98% more capital invested

Capital invested by funds: $446M → $884M (+$438M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

28% more funds holding

Funds holding: 68 → 87 (+19)

11% less call options, than puts

Call options by funds: $45.5M | Put options by funds: $51M

Holders
87
Holders Change
+19
Holders Change %
+27.94%
% of All Funds
2.5%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
36
Increased
31
Reduced
11
Closed
16
Calls
$45.5M
Puts
$51M
Net Calls
-$5.47M
Net Calls Change
-$5.52M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$73.3M
2
CPM
Chesapeake Partners Management
Maryland
+$13.8M
3
VAM
Visium Asset Management
New York
+$8.01M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$6.37M
5
Jane Street
Jane Street
New York
+$6.03M

Top Sellers

Rank Fund Capital Flow
1
VM
VHCP Management
New York
-$23.1M
2
FCM
Farallon Capital Management
California
-$21.7M
3
RG
Redmile Group
California
-$19.2M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.6M
5
A
Abingworth
United Kingdom
-$6.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
26
Laurion Capital Management
New York
$4.3M +$2.79M +40,100 New
DM
27
Deerfield Management
New York
$4.29M +$2.78M +40,000 New
GACM
28
Green Arrow Capital Management
New York
$4.29M +$2.78M +40,000 New
HCMT
29
Highland Capital Management (Texas)
Texas
$3.71M +$2.41M +34,611 New
U
30
UBS
Switzerland
$3.67M +$1.93M +27,736 +428%
NFA
31
Nationwide Fund Advisors
Ohio
$2.89M – – –
EAM
32
Eventide Asset Management
Massachusetts
$2.68M +$1.74M +25,000 New
MOACM
33
Mutual of America Capital Management
New York
$2.25M -$87.8K -1,263 -6%
GTC
34
Ghost Tree Capital
New York
$2.15M -$348K -5,000 -20%
SGH
35
Schonfeld Group Holdings
New York
$2.01M +$991K +14,246 +320%
PCA
36
Private Capital Advisors
Connecticut
$1.79M +$1.16M +16,700 New
Group One Trading
37
Group One Trading
Illinois
$1.74M +$940K +13,522 +507%
DCM
38
Driehaus Capital Management
Illinois
$1.71M -$2.2M -31,596 -67%
VKH
39
Virtu KCG Holdings
New York
$1.44M +$935K +13,441 New
LPL Financial
40
LPL Financial
California
$1.41M +$913K +13,135 New
Commonwealth Equity Services
41
Commonwealth Equity Services
Massachusetts
$907K +$195K +2,807 +50%
Goldman Sachs
42
Goldman Sachs
New York
$754K +$334K +4,807 +217%
EI
43
EAM Investors
California
$751K +$487K +7,002 New
QT
44
Quantbot Technologies
New York
$741K +$481K +6,910 New
GA
45
Geneva Advisors
Illinois
$696K +$451K +6,485 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$679K +$154K +2,209 +54%
ICAS
47
Investors Capital Advisory Services
Massachusetts
$650K +$421K +6,061 New
Citigroup
48
Citigroup
New York
$563K +$278K +3,997 +317%
CSS
49
Cubist Systematic Strategies
Connecticut
$496K +$321K +4,619 New
CS
50
Credit Suisse
Switzerland
$393K -$1.05M -15,140 -81%
1
2
3 4 5

GWPH Hedge Fund Activity: Q2 2014 in Review

87 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2014, worth a combined $884M — up 98% from $446M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new GWPH positions and 16 closed out — a net gain of 20 holders — while 31 added to existing stakes and 11 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $73.3M. The largest seller was VHCP Management, cutting an estimated $23.1M.

  • 87 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2014, up from 68 in Q1 2014.
  • Funds reported $884M of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2014, up 98% quarter-over-quarter.
  • 36 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2014 and 16 closed out, a net change of +20 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q2 2014 was Capital Research Global Investors, an estimated $73.3M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2014 was VHCP Management, an estimated $23.1M sold.

Based on aggregated 13F filings for Q2 2014.